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Abstract
Background: The development of metastases involves the dissociation of cells from the primary tumor to penetrate the
basement membrane, invade and then exit the vasculature to seed, and colonize distant tissues. The last step,
establishment of macroscopic tumors at distant sites, is the least well understood. Four isogenic mouse breast cancer cell
lines (67NR, 168FARN, 4TO7, and 4T1) that differ in their ability to metastasize when implanted into the mammary fat pad
are used to model the steps of metastasis. Only 4T1 forms macroscopic lung and liver metastases. Because some miRNAs are
dysregulated in cancer and affect cellular transformation, tumor formation, and metastasis, we examined whether changes
in miRNA expression might explain the differences in metastasis of these cells.
Methodology/Principal Findings: miRNA expression was analyzed by miRNA microarray and quantitative RT–PCR in
isogenic mouse breast cancer cells with distinct metastatic capabilities. 4T1 cells that form macroscopic metastases had
elevated expression of miR-200 family miRNAs compared to related cells that invade distant tissues, but are unable to
colonize. Moreover, over-expressing miR-200 in 4TO7 cells enabled them to metastasize to lung and liver. These findings are
surprising since the miR-200 family was previously shown to promote epithelial characteristics by inhibiting the
transcriptional repressor Zeb2 and thereby enhancing E-cadherin expression. We confirmed these findings in these cells.
The most metastatic 4T1 cells acquired epithelial properties (high expression of E-cadherin and cytokeratin-18) compared to
the less metastatic cells.
Conclusions/Significance: Expression of miR-200, which promotes a mesenchymal to epithelial cell transition (MET) by
inhibiting Zeb2 expression, unexpectedly enhances macroscopic metastases in mouse breast cancer cell lines. These results
suggest that for some tumors, tumor colonization at metastatic sites might be enhanced by MET. Therefore the epithelial
nature of a tumor does not predict metastatic outcome.
Citation: Dykxhoorn DM, Wu Y, Xie H, Yu F, Lal A, et al. (2009) miR-200 Enhances Mouse Breast Cancer Cell Colonization to Form Distant Metastases. PLoS
ONE 4(9): e7181. doi:10.1371/journal.pone.0007181
Editor: Mikhail V. Blagosklonny, Roswell Park Cancer Institute, United States of America
Received July 28, 2009; Accepted September 5, 2009; Published September 29, 2009
Copyright:  2009 Dykxhoorn et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This research was supported by grant W81XWH-09-1-0058 from the DOD Breast Cancer Research Program (JL). HX is supported by a graduate
fellowship from the Singapore-MIT Alliance (SMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: lieberman@idi.harvard.edu (JL); ddykxhoorn@med.miami.edu (DMD)
Introduction
miRNAs are small ,22 nucleotide RNAs that regulate gene
expression post-transcriptionally in a sequence-specific manner to
influence cell differentiation, survival and response to environ-
mental cues [1,2]. Each miRNA may regulate the expression of
many target genes [3]. Dysregulation of miRNA expression has
been linked to tumor development and metastasis. miRNAs can
act as tumor suppressors (e. g. miR-15a and miR-16-1 [4]),
oncogenes (e. g. miR-155 [5,6] and miR-21 [7,8,9,10]) and as
promoters (e. g. miR-10b, miR-182 and miR-29a [11,12,13]) or
suppressors (e. g. miR-335 and miR-126 [14]) of metastasis. The
let-7 family of miRNAs is poorly expressed in human breast
tumor-initiating cells (BT-IC) and increases as they differentiate.
let-7 regulates self-renewal and differentiation by silencing H-RAS
and HMGA2 expression, respectively [15]. Exogenous expression
of let-7 reduces both primary tumor formation and metastasis of
BT-IC in immunodeficient mice.
Two leading theories about the origin of metastases are the
cancer stem cell hypothesis [16–20] and the EMT hypothesis
[21,22]. The former suggests that just as tumor-initiating cells with
stem cell properties may be responsible for initiating a primary
tumor, they also play an important role in initiating a metastasis.
The latter suggests that in epithelial tumors, cells on the periphery
of the tumor receive signals from the surrounding stroma, which
confer mesenchymal properties allowing cells to detach from
neighboring cells and become motile. These two competing
theories may actually be complementary, since breast cancer stem
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important role in tissue remodeling during embryonic develop-
ment [25]. One of the hallmarks of EMT is loss of E-cadherin
expression. E-cadherin is a Ca
2+-dependent transmembrane
glycoprotein that plays an important role in the maintenance of
cell polarity by mediating cell-cell and cell-substratum adhesion. In
addition, the intracellular domain of E-cadherin interacts with the
cytoskeleton through its association with the catenins. The EMT
involves the loss of cell-cell adherence through the repression of E-
cadherin (Cdh1) expression and the rearrangement of the
cytoskeleton. This causes the cells to adopt a more elongated
appearance resembling fibroblasts and facilitates cellular motility,
a key event in tumor invasiveness. The EMT can be triggered by
the expression of various transcription factors, including the E-box
binding factors Snai1 (snail) and Snai2 (slug), in response to soluble
factors present in the tumor microenvironment, such as TGFb
[26,27]. The transcriptional repressors, Zeb1 (TCF8 or dEF1) and
Zeb2 (ZFXH1b or SIP1), suppress the epithelial phenotype by
inhibiting E-cadherin expression. During normal development, the
EMT can sometimes be reversed (referred to as the mesenchymal-
to-epithelial transition (MET)) as a necessary step in tissue
construction (for example, the formation of kidney epithelium
from the nephric mesenchyme). Some recent studies suggest that a
reversion of the mesenchymal phenotype of malignant cells may
facilitate the establishment of macroscopic metastases [22,25,28].
The development of metastases requires that primary tumor
cells acquire genetic or epigenetic variations that allow them to
complete the required steps in metastasis - intravasation, survival
in the circulatory system, extravasation, and survival and growth
in distant tissues. Although miRNAs have been identified that
regulate the formation of metastases, these studies have principally
examined the early stages of metastasis and not the formation of
macroscopic metastatic nodules [11,14]. To begin to address
factors that regulate the final step of metastasis (colonization of
distant tissues), we took advantage of four well-characterized
mouse mammary tumor cell lines derived from a single
spontaneously arising, mammary tumor in a BALB/c mouse
[29]. Although each of these tumor cells (67NR, 168FARN, 4TO7
and 4T1) is able to form primary tumors when implanted into the
mammary gland of BALB/c mice, they have different metastatic
properties. 67NR cells form primary tumors readily, but tumor
cells do not intravasate. 168FARN cells can be detected in lymph
nodes but rarely in other tissues, suggesting that they can enter the
vasculature, but extravasate inefficiently. 4TO7 cells can dissem-
inate from primary mammary tumors into the lungs but don’t
form visible lung nodules. Moreover, disseminated 4TO7 cells in
the lungs rapidly disappear when the primary tumor is removed,
suggesting that they are unable to colonize distant sites. 4T1 cells
are fully metastatic and form macroscopic lung nodules from
primary mammary tumors. Implantation of syngeneic breast
tumor cells within the mammary gland of immunocompetent mice
may more accurately mimic in vivo tumor formation in the
context of all stromal factors than models involving xenotrans-
plantation in immunodeficient mice.
Since 4TO7 cells can perform all of the steps in metastases
except forming macroscopic metastatic nodules, we compared
miRNA expression in 4TO7 cells with the highly metastatic 4T1
cells to determine if miRNAs might play a role in this important
transition. Expression of some members of the miR-200 family of
miRNAs (miR-429, miR-200b, and miR-200c) was increased
more than 100-fold in 4T1 cells compared to 4TO7 cells.
Although highly homologous, the miR-200 family members (miR-
141, miR-429, miR-200a, miR-200b and miR-200c) can be
divided into two functional groups based on their seed sequences,
nucleotides 2 to 7 of the miRNA, which play an important role in
target recognition. The 2 groups differ by a single seed nucleotide -
miR-200b, miR-429 and miR-200c share the 59-AAUACU-39seed
sequence and miR-200a and miR-141 have the 59-AACACU-39
seed. In addition, they are encoded from 2 gene clusters in mice -
miR-200c and miR-141 on chromosome 6 and miR-200b, miR-
200a and miR-429 on chromosome 4. In agreement with recent
papers [30–37], we found that the miR-200 family members target
the transcriptional repressor Zeb2. As a consequence of Zeb2
silencing, E-cadherin levels increase, leading to the adoption of a
more epithelial phenotype. However, unlike the published reports,
we found that Zeb2 suppression and the resulting increase in E-
cadherin enhanced the metastasis of 4TO7 cells, allowing them to
form macroscopic lung nodules. These results suggest that
reestablishing an epithelial-like phenotype may be important for
effective colonization of distant tissue sites by some tumors.
Results
The miR-200 family is up-regulated in 4T1 cells
The most prominent change in miRNA expression by
microarray analysis between the three cell lines not able to
colonize distant sites (67NR, 168FARN and 4TO7 cells) and 4T1
cells was up-regulation of several members of the miR-200 family
in 4T1 cells (Figure 1A, Table S1). The cells incapable of
colonization had very low to undetectable expression of all miR-
200 family members, while 4T1 cells expressed miR-429, miR-
200b and miR-200c. These microarray results were verified by
qRT-PCR (Figure 1B). Higher expression of the miR-200 family
in the cell line capable of forming distant metastases was
unexpected since the miR-200 family has been linked to epithelial
differentiation [30–36] that is normally associated with decreased
metastatic potential. In fact, expression of miR-429, miR-200b
and miR-200c was elevated in the highly metastatic 4T1 cells but
absent from 4TO7 cells, which can perform all of the steps leading
up to the establishment of lung metastases except establishing the
secondary tumor. Neither miR-200a nor miR-141 expression was
detected in any of the cell lines, which is surprising since they
would be expected to be co-expressed on the same primary
transcript with the other clustered miRNAs. This suggests that
either the specific probes for these miRNAs on the microarrays are
not efficient at detecting these family members or that these
isoforms might be differentially processed compared to the other
family members, as has been recently shown to be the case for
miR-181 family members [38]. The lack of miR-200a and miR-
141 expression was confirmed by quantitative RT-PCR analysis
(data not shown).
The miR-200 target gene Zeb2 is down-regulated and E-
cadherin is up-regulated in 4T1 cells
The TargetScan5.0 algorithm identified the zinc finger E-box
binding homeobox 2 (Zeb2/SIP1/ZFXH1B) gene as the highest
likelihood target gene of the miR-200 family with 6 potential miR-
429/miR-200b/miR-200c binding sites and an additional 3
potential miR-141/miR-200a binding sites in its 39UTR. Zeb2
protein was strongly expressed in 67NR, 168FARN and 4TO7
cells, but suppressed in 4T1 cells (Figure 2A). Zeb2 mRNA levels
were significantly higher in 67NR cells than in the other cell lines,
which had similar levels (Figure 2B). The low expression of Zeb2
protein in 4T1 cells relative to 168FARN and 4TO7 cells is
consistent with inhibition of Zeb2 translation by miR-200.
However, other post-transcriptional mechanisms (including other
miRNAs) might explain the lack of difference in Zeb2 protein
between 67NR and 168FARN and 4TO7 cells. Consistent with
miR-200 Enhances Metastasis
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4T1 cells, which have low endogenous levels of Zeb2, have high
E-cadherin mRNA and protein (Figure 2C and 2D). Surprisingly,
N-cadherin (Cdh2) mRNA and protein, a mesenchymal marker
often reciprocally expressed with E-cadherin, was only detected in
non-metastatic 67NR cells (Figure 2C and 2E). Immunoblot
analysis showed that vimentin was most highly expressed in 67NR
cells, but was comparable in the other 3 cell lines (Figure 2C).
Vimentin mRNA was similar in all 4 cell lines. Expression of the
epithelial cell-associated intermediate filament cytokeratin 18 (CK-
18) mRNA was limited to 4TO7 and 4T1 cells and was higher in
4T1 cells [39] (Figure 2F). In addition, expression of Epidermal
Growth Factor Receptor (EGFR) mRNA was restricted to 4T1
cells (Figure 2F). These data suggest that contrary to the EMT
hypothesis, the nonmetastatic 67NR cells have a mesenchymal
phenotype, while the metastatic cell lines have features of both
mesenchymal and epithelial cells. Paradoxically, the most
metastatic 4T1 cells have more epithelial characteristics based
on enhanced Cdh1, CK-18 and EGFR expression, than the less
metastatic cells.
miR-200 over-expression in 4TO7 cells reduces Zeb2 and
Snai1 and increases E-cadherin expression
To determine whether miR-200 regulates Zeb2 and E-cadherin
expression in these breast cancer cell lines, we transfected 4TO7
cells with mimics of miR-200b or miR-200c alone or in
combination. Over-expressing either miR-200b or miR-200c or
both led to a loss of Zeb2 expression and a concomitant increase in
E-cadherin (Cdh1) levels (Figure 3A). To test the direct targeting of
Zeb2 by miR-200, the complete Zeb2 39-UTR was cloned
Figure 1. MiR-200 family member expression distinguishes highly metastatic 4T1 cells from 67NR, 168FARN, and 4TO7 cells. (A)
miRNA microarray analysis of miR-200 family expression in 4 isogenic mouse breast cancer cell lines. The seed sequence (nucleotides 2–7) of the
miRNA is underlined. No significant signal was detected for miR-200a and 141 (N.D.=not detected), averaged signal for all samples below 500), but
the remaining miR-200 family members were highly expressed in 4T1 cells relative to the less metastatic 67NR, 168FARN, and 4TO7 cells. (B) miR-200
family expression, analyzed by qRT–PCR and normalized to U6 snRNA, confirms the microarray data. miR-23a, which is expressed in all the lines, was
analyzed as a control (*, p,0.001; **, p,0.002; #,p ,0.04). Data represent the mean and standard deviation from 3 independent experiments.
doi:10.1371/journal.pone.0007181.g001
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the reporter plasmid with miR-200b and/or 200c in the 4TO7 cells
significantly reduced luciferase expression (,5-fold, p,0.0002),
confirming previous reports [30,32,35] that these miRNAs suppress
Zeb2 expression by recognizing sites in its 39-UTR (Figure 3B).
Transfection of both miR-200b and miR-200c had no added effect,
presumably because these miRNAs redundantly bind to the same
miRNA recognition sites (MRE). (Although Zeb1 is not expressed
in any of the 4 cell lines under study (data not shown), the Zeb1
39-UTR was also regulated in 4TO7 cells by miR-200b and miR-
200c byluciferase assay(Figure S1).)Theexpression ofseveralgenes
involved in determining the epithelial or mesenchymal nature of
cells were also analyzed by qRT-PCR in 4TO7 cells which had
beentreated with the miR-200c mimic,an siRNA against Zeb2 or a
control siRNA (Figure 3C). Zeb2 mRNA was significantly
decreased in 4TO7 cells treated with either the Zeb2 siRNA or
the miR-200c miRNA mimic. Conversely, E-cadherin mRNA
increased in cells transfected with either Zeb2 siRNA (2.1-fold) or
miR-200c mimic (2.5-fold). Transcripts for vimentin and N-
cadherin, markers of mesenchymal cells, were not significantly
altered by the miR-200c mimic, although N-cadherin mRNA was
slightly,butsignificantly,decreasedin the Zeb2 siRNA-treated cells.
In addition, mRNA for the mesenchymal transcription factor Snai1
was significantly reduced in 4TO7 cells transfected witheither Zeb2
siRNA or miR-200c mimic. Unlike Zeb2, Snai1 is not a predicted
target of the miR-200 family. The decrease in Snai1 mRNA after
treatment with miR-200c could be secondary to Zeb2 silencing
and/or to recognition of a noncanonical MRE in Snai1.
Exogenous miR-200 expression enhances the epithelial
morphology of 4TO7 cells
The effect of exogenous miR-200 expression on E-cadherin
expression and cell morphology of 4TO7 cells was also analyzed
by fluorescence microscopy (Figure 4). In support of the
immunoblot and qRT-PCR data, E-cadherin was readily detected
in 4T1 cells, but not in 4TO7 cells. In line with this, 4TO7 cells
Figure 2. Protein expression of Zeb2 protein negatively correlates and E-cadherin positively correlates with miR-200 expression. (A)
Zeb2 protein, analyzed by immunoblot relative to a-tubulin as a loading control, is significantly lower in 4T1 cells. (B) Zeb2 mRNA, analyzed by qRT-
PCR and normalized to Gapdh, is higher in 67NR cells but similarly expressed in the other cell lines. Snail mRNA is somewhat lower in 4T1 cells than
the other cell lines. (C–E) E-cadherin protein (C) and mRNA (D) expression is only detected in 4T1 cells, while N-cadherin protein (C) and mRNA (E) is
restricted to 67NR cells. Vimentin protein (C) is expressed in all 4 cell lines, but expression is greater in 67NR cells, while vimentin mRNA is expressed
at similar levels in all 4 cell lines (F). Cytokeratin-18 (CK-18) mRNA is expressed in 4TO7 and 4T1 cells, while Epidermal Growth Factor Receptor (EGFR)
is limited to 4T1 cells (F). Protein was analyzed relative to a-tubulin by immunoblot and mRNA was quantified by qRT-PCR relative to Gapdh. Levels of
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4T1 cells, which had epithelial morphology and adhered to their
neighbors. E-cadherin in 4T1 cells concentrated at intercellular
junctions. Transfection of miR-200b and/or miR-200c in 4TO7
cells increased E-cadherin expression, which also concentrated at
cell junctions and shifted 4TO7 morphology from spindle-shaped
cells to cobblestone-forming epithelial cells.
To evaluate the effect of miR-200 and Zeb2 on tumor
formation and metastasis, we next engineered retroviruses
encoding the miR-141-200c cluster mature miRNAs or control
virus expressing firefly luciferase shRNA or Zeb2 shRNA within
the miR-30 stem. Infection with these retroviruses allowed us to
produce 4TO7 cell lines that stably expressed the miR141-200c
cluster or had stably knocked-down Zeb2. Stable expression of the
miR-200c cluster in 4TO7 cells increased miR-200c expression to
,3-fold higher than that of 4T1 cells as measured by qRT-PCR
(Figure 5A). As expected, the miR-200c cluster-transfected cells
expressed E-cadherin protein, which was undetected in the control
virus-treated cells (Figure 5B). They also adopted an epithelial-like
morphology (Figure 5C). This same phenotype was recapitulated
in 4TO7 cells that had stably silenced Zeb2 expression (Figure 5D
and 5E)). 4TO7 cells over-expressing miR-200 or knocked down
for Zeb2 morphologically resembled 4T1 cells.
miR-200 expression does not alter colony formation or
cell proliferation, but enhances cell motility in vitro
One measure of the tumorigenic nature of cells is the ability to
form colonies in soft agar. To determine the effect of miR-200c
cluster expression on colony formation, soft agar assays were
performed using 4TO7 cells that were untreated or stably
expressed a control vector, the miR-141-200c cluster, or a Zeb2
shRNA. Altering miR-200 or Zeb2 expression did not significantly
change the number or size of colonies (Figure 6A, data not shown).
Consistent with these results, transient transfection of 4TO7 cells
with either the miR-200c mimic or a Zeb2 siRNA (Figure 3C) did
not significantly alter the rate of cell proliferation assayed by
thymidine incorporation (Figure 6B).
We next performed transwell migration assays to determine the
effect of miR-200b and miR-200c expression on the ability of 4TO7
cells to penetrate through an 8-mm porous membrane overlaid
Figure 3. Over-expression of miR-200 in 4TO7 cells down-regulates Zeb2 expression, resulting in increased E-cadherin. (A) Zeb2
expression decreases and E-Cadherin (Cdh1) expression increases, analyzed by immunoblot relative to Gapdh, after transfection of 4TO7 cells with miR-
200b and/or miR-200c. (B) miR-200 regulates the Zeb2 39-UTR in a luciferase reporter assay. 4TO7 cells were co-transfected with the Zeb2 39-UTR luciferase
plasmidoracontrolvectorandeitherthecontrol(ctl),miR-200band/ormiR-200cmiRNAmimics.Themeanandstandarddeviationoftherelativeluciferase
activity, normalized relative to that of mock-transfected cells, from 3 independent experiments is shown (*p,0.0002). (C) Comparison of mRNA levels of
epithelial and mesenchymal markers (Cdh1, Cdh2, vimentin (Vim), Zeb2, and Snai1) in 4TO7 cells transfected with miR-200c mimic or an siRNA targeting
Zeb2 (Zeb2 siRNA) or control (ctl) siRNA, analyzed by qRT–PCR normalized to the housekeeping gene Ubc. miR-200c expression increased Cdh1 mRNA, an
epithelial marker, and decreased Snai1 and Zeb2, mesenchymal markers, but had no effect on N-cadherin (cdh2) or vimentin (Vim). Knocking down Zeb2
hada similareffectas expressing miR-200c, except that Cdh2 mRNA was also significantly suppressedby reducingZeb2.Mean andstandarddeviationfor3
independent experiments are shown relative to the results for mock-transfected cells (*,p,0.05, **,p,0.01, ***,p,0.005, #,p,0.001 and ##,p,0.0001).
doi:10.1371/journal.pone.0007181.g003
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PLoS ONE | www.plosone.org 5 September 2009 | Volume 4 | Issue 9 | e7181Figure 4. Over-expression of miR-200 in 4TO7 cells converts fibroblastic cells to an epithelial morphology. (A) Phase contrast
microscopy of 4TO7 cells that were either mock treated or transfected with the miRNA control (ctl), miR-200b, or miR-200c mimic. The white bar
represents 10 mm. (B) E-cadherin expression visualized by fluorescence microscopy of parental 4T1 and 4TO7 cells (top) and 4TO7 cells that were
transfected with miR-200b and/or miR-200c or control mimics (bottom). 4TO7 cells treated with either of the miR-200 mimics adopted an epithelial-
like morphology and expressed high levels of E-cadherin, similar to the highly metastatic 4T1 cells. E-cadherin (Cdh1) concentration at the cell-cell
junction is shown in the magnified image. Cell nuclei were stained with DAPI.
doi:10.1371/journal.pone.0007181.g004
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paran sulfate proteoglycans,entactin/nidogen).Consistent with their
enhanced metastatic potential, ,3 times as many 4T1 cells migrated
across the transwell as unmanipulated 4TO7 cells (Figure 6C).
Transient over-expression of miR-200b and/or miR-200c in 4TO7
cells increased the number of migrating cells to that of 4T1 cells.
Mocktransfection ortransfectionof 4TO7 cellswith controlmiRNA
mimic had no effect on migration. Therefore, enhanced epithelial
characteristics induced by miR-200 mimics did not impair, but
rather enhanced, the in vitro migration of 4TO7 cells.
miR-200 expression in 4TO7 cells confers in vivo
metastatic potential
Since the most relevant test of metastatic potential is formation
of metastases in vivo, we next assessed tumor growth and
metastases after 2 doses (1.25610
5 and 5610
5 cells) of stably
transduced 4TO7 cells or parental 4TO7 and 4T1 cells were
implanted into the mammary fat pads of BALB/c mice (Figure 7A
and 7B). For both cell doses, all mice injected with 4T1 cells
formed primary tumors, but only half of the mice injected with
these numbers of 4TO7 cells formed tumors. Moreover, 4T1 cells
formed palpable tumors at both doses more rapidly than 4TO7
cells. While 5610
5 implanted 4T1 cells reached 1 ml tumor
volume in ,22 d, the same number of 4TO7 cells took almost
twice as long to reach the same size in those mice which grew
tumors. Although there was a longer lag time before the 4TO7
cells became palpable, once they could be detected their doubling
time was indistinguishable from that of 4T1 cells at both cell doses.
4TO7 cells infected with the control retrovirus grew out
comparable numbers of tumors and with the same kinetics as
unmodified 4TO7 cells, while 4TO7 cells stably expressing miR-
141-200c grew tumors like 4T1 cells.
Figure 5. Stable miR-141-200c over-expression or Zeb2 silencing in 4TO7 cells promoted adoption of an epithelial-like
morphology. (A) miR-200c expression is increased in 4TO7 cells stably expressing the miR-141-200c cluster from a retroviral vector. miR-200c levels,
normalized to U6 snRNA expression, are shown relative to expression in 4T1 cells. Mean and standard deviation of 3 independent experiments are
shown (*, p=0.02, relative to 4T1 cells). (B) Stable over-expression of the miR-141-200c cluster leads to an increase in E-cadherin expression, as
measured by immunoblot relative to a-tubulin. (C) The stable miR-141-200c-expressing 4TO7 cells adopt an epithelial morphology compared to the
control transfected cells or the parental cells when examined by phase contrast microscopy. 4TO7 cells stably expressing a Zeb2 shRNA had reduced
Zeb2 and concomitantly increased E-cadherin protein by immunoblot (D), and altered morphology from a fibroblastic to an epithelial morphology
(E). 4T1 cells are shown for comparison. The white bars represent 10 mm.
doi:10.1371/journal.pone.0007181.g005
miR-200 Enhances Metastasis
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diameter or when the mouse became moribund or 50 d post
implantation for mice that didn’t develop tumors. At the time of
sacrifice, lung, liver and brain were harvested and tissue sections
were stained with hematoxylin and eosin (HE) and analyzed for
metastases (Figure 7A, Figure 8A). Metastases were confirmed by
immunohistochemistry staining for proliferating cell nuclear
antigen (PCNA) (Figure S2). All mice injected with 4T1 cells
developed both lung and liver metastases. No brain metastases
were detected in any mice injected with these numbers of cells. On
the other hand, none of the mice injected with 4TO7 cells had
evident metastases. Similarly, only 1 of 7 mice that received the
higher dose of cells transduced with the control retrovirus had a
lung metastasis. In contrast, most mice that received 4TO7 cells
stably expressing the miR-141-200c cluster had lung metastases
(5/7 at the higher dose and 6/7 at the lower dose). Therefore,
4TO7 tumors stably expressing the miR-141-200c cluster behaved
like the more malignant 4T1 cells in vivo.
Because the association of epithelial characteristics with
enhanced metastases was unexpected, we wanted to verify that
E-cadherin continued to be expressed in transduced tumors in
vivo. The primary tumors and lung metastases derived from 4T1
and 4TO7 cells transduced to express miR-141-200c stained
strongly for E-cadherin, while no significant E-cadherin staining
was detected in the 4TO7 tumors derived from cells that were
either unmodified or infected with the control retrovirus
(Figure 8B). qRT-PCR analysis also confirmed that elevated E-
cadherin mRNA levels were maintained in the primary tumors
derived from the miR-141-200c transduced 4TO7 cells
(Figure 8C).
Discussion
To begin to understand the molecular mechanisms that regulate
the last step of metastasis - the ability to colonize distant tissues to
form macroscopic metastases, we compared the miRNA profile of
the isogenic, mouse mammary tumor cell lines, 4TO7 and 4T1.
Although both of these cell lines can form primary tumors,
intravasate, survive in the circulation and extravasate into the
lungs, only the 4T1 cells form macroscopic metastases. The
members of the miR-200 family of miRNAs (miR-200b, miR-200c
and miR-429) were highly expressed in 4T1 cells but undetectable
in 4TO7 cells. These miRNA were shown to target the
transcriptional regulator, Zeb2. Zeb2, a master regulator of the
mesenchymal state, exerts its effect by binding to E-box elements
upstream of many genes, including E-cadherin, and repressing
their transcription. As a consequence of miR-200 expression, 4T1
cells have reduced Zeb2 expression and high E-cadherin
expression compared to 4TO7 cells. Consistent with this effect,
4T1 cells have an epithelial morphology with extensive cell-cell
contacts while the 4TO7 cells looked more fibroblastic. Over-
expression of miR-200b and/or miR-200c in 4TO7 cells, either by
transient transfection of miRNA mimics or infection with a miR-
141-200c cluster-expressing retrovirus, led to a loss of Zeb2
expression, an increase in E-cadherin expression and the
acquisition of an epithelial-like morphology. This miRNA-
mediated silencing of Zeb2 was the result of the directed targeting
of the Zeb2 39UTR by the miR-200 family, as previously reported
[30–37]. These studies also showed that miR-200 expression
enforces an epithelial phenotype in tumor cells, as we confirmed
here in these mouse breast cancer cells. Based on the EMT
Figure 6. miR-200 enhances 4TO7 cells migration through a basement membrane, but does not affect cell proliferation. (A)
Exogenous expression of the miR-141-200c cluster (compared to the control vector expressing luciferase shRNA) or Zeb2 shRNA (compared to a
luciferase shRNA construct) in 4TO7 cells does not alter colony growth in soft agar. Parental 4TO7 and 4T1 cells also are equally efficient at forming
colonies. (B) Cell proliferation as measured by thymidine incorporation is also unaffected in 4TO7 cells expressing miR-200c mimic or Zeb2 siRNA. The
mean and standard deviation of 6 independent experiments is shown. (C) Transient over-expression of miR-200b and/or miR-200c enhances the
migration of the 4TO7 cells through a basement membrane to the same level as the highly invasive 4T1 cells. The mean and standard deviation from
analyzing five fields from triplicate samples is shown (*, p,0.01, compared to untreated (parental) 4TO7 cells).
doi:10.1371/journal.pone.0007181.g006
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expression would lead to a decrease in metastasis. Surprisingly, our
results with this series of isogenic mouse mammary tumor cells
showed the opposite effect - expression of miR-200 family
members either endogenously in 4T1 cells or by retroviral
transduction in 4TO7 cells enhanced both in vitro motility and
in vivo metastases. In fact, in the 4 related cell lines that arose from
the same spontaneously arising cancer cell clone, mesenchymal
gene expression (N-cadherin, vimentin) was greatest in the
nonmetastatic cell line (67NR) and decreased with increased
metastatic potential, while epithelial gene expression of E-
cadherin, CK-18 and EGFR followed the opposite trend.
However, the 4T1 and miR-200-expressing 4TO7 cells retained
some vimentin expression, suggesting that they may have some
characteristics of both epithelial and mesenchymal cells.
Our results suggest that, at least in some tumors, epithelial
properties may enhance the ability of tumor cells to colonize both
primary and metastatic tissue sites. 4T1 cells and miR-200-
expressing 4TO7 cells did not differ from parental 4TO7 cells in
proliferative rate in vitro or growth in soft agar, but they both
established primary tumors more rapidly and were capable of
colonizing distant tissues. Although there was a delay in detecting
4TO7 primary tumors relative to 4T1 or miR-200-expressing
4TO7 tumors, once tumors became palpable, mathematical
modeling did not show any significant change in their doubling
times (data not shown). This suggests that epithelial characteristics
enhanced colonization, but did not offer a growth advantage once
a tumor had established itself.
Although the hypothesis that EMT is an important feature of
metastasis has many compelling features and experimental
support, other data suggest that metastasis by some tumors can
be governed by processes other than EMT. The morphology and
E-cadherin expression of metastatic tumors generally resembles
that of the primary tumor. This has been interpreted as a potential
requirement for EMT to accomplish the first steps of metastasis
and a reversion (MET) to accomplish the final step of colonization.
However, in this breast cancer model, the epithelial-like 4T1 cells
could efficiently accomplish all the steps of metastasis, including
the early steps. In fact, the more epithelial 4T1 and miR-200-
expressing 4TO7 cells were better able to traverse an artificial
basement membrane in vitro than their more mesenchymal
relatives. However, the epithelial/mesenchymal properties of a
tumor cell in vivo are not fixed. Properties of some tumor cells,
particularly those at the periphery of the cancer that are closely
associated with the tumor stroma, are plastic and can be
modulated by response to stromal cytokines or binding to stromal
receptor ligands. We cannot rule out that some of the 4T1 or miR-
200-expressing 4TO7 cells transiently became E-cadherin- and
more mesenchymal in vivo under the influence of local stromal
factors. However, the more economical explanation of our
surprising findings is that a complete EMT is not required for
any of the metastatic steps in this tumor model. It may well be that
these transformed cells are hybrid cells with some mesenchymal
properties, as evidenced by their expression of vimentin mRNA
and protein, that confer motility and invasive capability.
Although an inverse correlation between E-cadherin and
invasiveness has been found for many cancers, abundant examples
are inconsistent or contrary to this general assumption. Immuno-
histochemical analysis of mammary carcinoma expression of three
epithelial markers, E-cadherin, a-catenin and b-catenin, found
Figure 7. 4TO7 cells stably over-expressing miR-141-200c form tumors more rapidly that are more likely to metastasize. (A) Primary
tumor and metastases is enhanced in 4TO7 cells stably over-expressing the miR-141-200c cluster. The indicated number of cells was injected in the
mammary fat pad of female mice (*,p=0.02; **, p=0.07; #, p=0.1; ##, p=0.005). (B) Growth curves for primary tumors in mice injected with either
5610




PLoS ONE | www.plosone.org 9 September 2009 | Volume 4 | Issue 9 | e7181Figure 8. Primary tumors and metastases of 4TO7 cells stably expressing the miR-141-200c cluster express E-cadherin. (A)
Representative primary mammary tumors and lung and liver tissue sections stained with hematoxylin and eosin from mice implanted with parental 4T1
and 4TO7 cells or 4TO7 cells stably-expressing miR-141-200c or control vector. 4TO7 cells and 4TO7 cells expressing the control miRNA (miR-ctl) did not
form metastases. (B) Primary tumors and lung metastases formed from 4T1 cells and 4TO7 cells transduced with miR-141-200c retrovirus continue to
express E-cadherin,while primary tumors from 4TO7 parental cellsor 4TO7 cellsinfectedwith a control retrovirus remainE-cadherin-. (C)Primary tumors
from 3 mice implanted with 4TO7 cellsstably expressing miR-141-200c showed highlevelsof E-cadherin mRNA, analyzedby qRT-PCR andnormalized to
Gapdh, compared to parental 4TO7 cells. Mean and standard deviation from triplicate samples of each cell line or tumor are shown.
doi:10.1371/journal.pone.0007181.g008
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PLoS ONE | www.plosone.org 10 September 2009 | Volume 4 | Issue 9 | e7181that they were expressed in the majority of both organ-confined
intraductal breast carcinomas (100%) and invasive ductal car-
cinomas (,70%) [40]. In addition, no correlation between
metastatic status and epithelial marker expression was seen when
examining lymph-node positive and lymph-node negative tumors
[40]. Several groups have found that E-cadherin status of breast
carcinomas showed weak or no correlation with vascular invasion
[34], nodal status [41,42], the presence of metastases [34,41], and
disease recurrence or survival [34,41,42]. Similarly, E-cadherin
expression and desmosomal structure was maintained in invasive
colon carcinomas and their metastases [43]. Retrospective analysis
of gastric carcinomas by immunohistochemistry showed no
correlation between E-cadherin status and the depth of invasion,
lymph node status and level of vascular invasion in gastric
carcinomas [44].
A correlation between enhanced epithelial properties and tumor
metastasis similar to what we found here was previously reported
using in vivo passaged transitional bladder carcinoma, TSU-Pr1
(T24) cells [45,46]. Isogenic cell lines were derived from metastatic
bone tumors that arose in immunocompromised mice following
intracardiac inoculation. Although the cell lines developed from
the 1
st (TSU-Pr1-B1) and 2
nd (TSU-Pr1-B2) rounds of passaging
had enhanced metastatic potential compared to the parental cells,
they both showed enhanced epithelial characteristics, including
increased cell-cell adhesion, a decrease in vimentin and up-
regulation of epithelial intermediate cytokeratin filaments [45,46].
Moreover, reversion of epithelial characteristics to a mesenchymal
morphology (spindle-like fibroblastic cell shape) by silencing the
fibroblastic growth factor receptor IIIc subtype (FGFR2IIIc)
impaired the development of metastases and increased mouse
survival [46]. These results underlie the importance of cell-cell and
cell-substratum adhesion in the development of micrometastases
into macroscopic secondary tumors. The parental TSU-Pr1 cells,
like the 4TO7 cells used in this study, were able to intravasate,
survive in the circulatory system, extravasate and form microme-
tastases in the lung but were defective in forming macroscopic
metastases. In each of these cases, the acquisition of epithelial
characteristics enhanced the metastatic potential of the cells
allowing for the transition from micrometastases to overt
secondary tumors.
Several miRNAs have been implicated in the regulation of early
steps of breast cancer metastasis (reviewed in [47]). miR-10b
promoted metastatic transformation of breast cancer cells, while
miR-373 and miR-520c enhanced extravasation and metastatic
development [11,48]. miR-21 has also been shown to inhibit the
expression of multiple metastasis suppressors [49,50]. miR-29a has
also been shown to promote mesenchymal properties and promote
metastasis of Ras-transformed mouse mammary epithelial cells
[13]. On the other hand, miR-335 and miR-126 inhibited
metastatic development [14]. In our study, some of these miRNAs
(miR-10b, miR-373, miR-520c and miR-29a) were not probed in
our microarrays and others (miR-21, miR-126 and miR-335)
showed no significant differences in expression amongst the 4
isogenic cell lines. There was a steady increase in miR-182
expression between the 67NR cells and the 4T1 cells with a 3.8-
fold increase overall. These findings suggest that alterations in
different miRNAs can regulate metastasis in different tumors. It is
likely that multiple combinations of transforming mutations and
alterations in miRNA expression can contribute to a metastatic
phenotype. In particular, it would be worthwhile to examine
whether the miR-200 family might have a role in regulating the
metastasis of different human breast cancer subtypes.
Although this paper is the first to show the direct enhancement
of metastasis by the miR-200 family, changes in miR-200 family
levels have been associated with enhanced tumorigenesis. Croce
and colleagues found that the miR-200 family (miR-200a, miR-
200b, miR-200c and miR-141) were upregulated in human
ovarian cancers compared to normal ovarian tissue [51]. This
up-regulation of miR-200 family members was particularly
pronounced in serous and endometroid histotypes. A subsequent
study confirmed this result in serous ovarian cancers [52].
Moreover, over-expression of the miR-200 family significantly
correlated with decreased survival. Patients with ovarian tumors
with high miR-200a expression had an approximately 50%
decrease in median survival time compared to those lacking
significant miR-200a expression (27.5 months vs. 61 months,
respectively [52]). The region on chromosome 1 from which the
human miR-200a-429 cluster is encoded was also found to be
amplified in several epithelial cancers - ovarian cancer, breast
cancer and melanoma [53]. This same region was found to
undergo chromosomal gain in serous ovarian carcinoma samples
when examined by high-resolution array comparative genomic
hybridization [53,54]. In addition, members of the miR-200
family of miRNAs, miR-141 and miR-200b, were found to be
over-expressed in malignant cholangiocarcinoma cells compared
to non-malignant cells [55]. The chromosomal locus (12p13.31)
from which miR-141 and miR-200c are encoded is associated with
chromosomal gain in biliary tract cancers. Over-expression of
miR-141 or miR-200b is associated with an increase in
proliferation, while inhibition of these miRNAs impairs cell
proliferation. In addition, over-expression of miR-141 and miR-
200b correlates with resistance to gemcitabine treatment [55].
The formation of metastases requires the acquisition of genetic
or epigenetic changes that allow for the detachment of cells from
the primary tumor, transport and survival in the circulation and
the establishment of macroscopic tumors in distant organs. Given
the heterogeneity of oncogenic changes associated with different
tumor subtypes, it is likely that more than one pathway can
promote metastases. It is clear from this work and that of others
that miRNAs play an important role in regulating metastasis, the
ultimate cause of death of most cancer patients. Approaches that
alter miRNA expression levels, either inhibiting miRNAs that
promote the development of metastases or mimicking miRNAs




67NR, 168FARN, 4TO7 and 4T1 cells, a kind gift of Fred
Miller (Wayne State University) were grown in complete medium,
DMEM (Gibco) containing 10% fetal bovine serum (FBS)
supplemented with 1 mM L-glutamine, penicillin/streptomycin
and non-essential amino acids (Gibco).
miRNA microarray and data analysis
Total RNA was extracted using Trizol Reagent (Invitrogen) and
size fractionated using an YM-100 Microcon filter (Millipore). The
isolated small RNAs (,300 nt) were 39-extended using poly(A)
polymerase and labeled with Cy5. Hybridizations were performed
on a microfluidic biochip platform (LC Sciences) using 100 mL
6xSSPE buffer (0.90 M NaCl, 60 mM Na2HPO4, 6 mM EDTA,
pH 6.8) containing 25% formamide at 34uC overnight. Hybrid-
ization images were collected on a laser scanner (GenePix 4000B,
Molecular Device) and digitized using Array-Pro image analysis
software (Media Cybernetics) with a scan resolution of 10 microns
and PTM between 480 and 540V. miRNA microarrays
corresponding to miRbase v9.0 (nine probes for each miRNA
miR-200 Enhances Metastasis
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Data were analyzed by background subtraction using a regression-
based background mapping method and normalization The
regression was performed on 5% to 25% of the lowest intensity
data points excluding blank spots. Raw data matrix was then
subtracted from the background matrix. Inter-array normalization
was carried out using a cyclic LOWESS (Locally-weighted
Regression) method. Normalized signals of all probes correspond-
ing to one miRNA were averaged for individual sample and shown
in the Table S1. All the miRNA microarray data is MIAME
compliant and both the raw and normalized data has been
deposited in the ArrayExpress database (accession number E-
MEXP-2289).
mRNA and miRNA quantification
Total RNA was prepared using Trizol Reagent (Invitrogen) and
reverse transcribed using random hexamers and Superscript III
reverse transcriptase. Quantitative real time PCR (qRT-PCR) was
performed in triplicate samples using platinum Taq polymerase
(Invitrogen) according to the manufacturer’s protocol with Syber
green detection using the BioRad iCycler. Results were normal-
ized to Gapdh or Ubc as indicated. All RT-PCR primers are listed
in Table S2. miRNA levels were quantified using TaqMan
miRNA Assay Kit, TaqMan miRNA Reverse Transcription Kit
and the Taqman 2X Universal PCR Master Mix, No AmpErase
UNG (Applied Biosystems) as per the manufacturer’s protocol. All
values were normalized to U6 snRNA (Applied Biosystems).
TargetScan analysis
To determine whether a gene was also a predicted target of
miR-200b and c, the presence of miR-200 family binding sites was
analyzed using TargetScan 5.0 (www.targetscan.org [56]).
siRNA and miRNA mimic transfection
4TO7 cells were transfected with miRNA mimics (miR-200b
and/or miR-200c) (Dharmacon) or Zeb2 or firefly luciferase
siRNAs using Lipofectamine 2000 (Invitrogen). Briefly, 6610
5 cells
wereplated/well ina 6-well plate the day prior to transfection.Prior
to transfection,medium wasaspirated andreplaced with OptiMEM
(Gibco). Lipid complexes, formed according to the manufacturer’s
protocol, were incubated with the cells for 4 h before culture
supernatants were aspirated and replaced with complete growth
medium.Cellswereharvested72 hposttransfectionformRNAand
protein analysis. The sequences of the sense and antisense strands of
the siRNAs [57] are found in Table S2.
Luciferase assay
4TO7 cells were co-transfected with 100 nM miRNA mimics
and 0.5 mg psiCHECK2 vector (Promega) encoding the 39-UTR
of Zeb2 or Zeb1 downstream of the Renilla luciferase gene using
Lipofectamine 2000 as above. Cells were lysed 24 h post
transfection in Passive Lysis Buffer (Promega) and luciferase
activity was measured using the Dual Luciferase Assay System
(Promega) on a Synergy2 plate reader (Biotek). The level of Renilla
luciferase activity was measured relative to firefly luciferase
expressed from the same vector. These values were compared to
the Renilla luciferase/firefly luciferase levels from a vector lacking
either the Zeb2 or Zeb1 39UTR. All values are relative to the
mock treated cells.
Immunoblot
Whole cell lysates were prepared using RIPA buffer (150 nM
NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM
Tris pH 8.0 containing Complete Mini-protease Inhibitor Cock-
tail (Roche)). Protein concentration was determined using the
BioRad DC protein assay kit (BioRad), and samples were resolved
on 10% SDS-Page gels and transferred using a Transblot semi-dry
transfer apparatus (BioRad). Blots were probed with antibodies to
Zeb2 (kind gift of Anders Lund, University of Copenhagen), Cdh1,
Cdh2 (BD Transduction), Vimentin (V5255, Sigma), and Zeb1
(AREB6) using ECL reagents (Pharmacia). a-tubulin and GAPDH
were used as loading controls. All antibodies were used at a 1:500
dilution.
Cloning
The miR-141-200c cluster was amplified from genomic DNA
purified using the DNeasy Blood and Tissue kit (Qiagen) by PCR
using the HiFidelity PCR Master Mix (Roche), digested with
BamHI and EcoRI and cloned into the pBabepuro retroviral
vector. The miR-30 stem containing an shRNA against firefly
luciferase was used as a negative control. The Zeb2 shRNA
constructs were cloned into pll3.7 according to Rubinson et al.
[58]. The primers used for the amplification of the miR-141-200c
cluster are listed in Table S2. The miRNA control contains a
luciferase shRNA cloned onto the stem of miR-30 [59], while the
control shRNA targets firefly luciferase cloned as an shRNA. The
primers used for cloning the shRNAs are listed in Table S2.
Fluorescence microscopy
4TO7 and 4T1 cells were plated on glass cover slips and either
left untreated or treated with miR-200b and/or miR-200c or a
control miRNA mimic. 72 h post transfection the cover slips were
washed extensively in phosphate buffered saline (PBS) and fixed
with 2% paraformaldehyde in PBS. After additional washing, the
cells were permeabilized with 0.2% Triton X-100 in PBS for
5 min. The cover slips were then washed and blocked with 10%
FBS in PBS for 30 min. The cells were labeled with E-cadherin
antibody (BD Transduction) in 10% FBS at RT for 2 h, washed
extensively with 0.05% Triton X-100 in PBS and treated with
Alexa488-conjugated donkey anti-mouse antibody (Molecular
Probes) for 30 min. After further washing, the cover slips were
mounted on glass slides with DAPI-containing Vectashield
mounting media (Vector Laboratories) and images were acquired
on an Axiovert 200 M microscope (Zeiss) using Slidebook
Software (Intelligent Imaging Solutions).
Soft agar assay
Tumor cells (5610
3) in complete medium containing 0.35%
agar were overlaid on complete medium containing 0.8% agar in
6 well plates. The cells were grown for 10 days at 37uC plus 5%
CO2. The number of colonies was determined by counting 5 fields
of view from triplicate wells for each cell line.
Thymidine incorporation
To measure cell proliferation, 4TO7 cells (5610
5 cells/well in
6-well plates) were seeded and after 24 h, transfected with miR-
200c mimics (50 nM) or siRNAs targeting Zeb2 or luciferase using
Lipofectamine 2000 (Invitrogen) following the manufacturer’s
protocol. After 48 h the cells in triplicate wells were incubated with
3H-thymidine (2 mCi/well) for 12 h and [
3H]-incorporation was
then measured using a liquid scintillation counter (Beckman).
Transwell migration assay
Cells, harvested 48 h post transfection using 5 mM EDTA in
PBS, were added (1.25610
5 cells/well) in serum free medium to
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added to the lower chamber. The invasion chambers were
processed 24 h later as per the manufacturer’s protocols, and
migrated cells were stained using the Hematoxylin Stain Solution,
Modified Harris Formulation (Amersco). Five random fields from
each of the triplicate invasion assays were counted using phase
contrast microscopy.
Tumor implantation
12-week old female BALB/cJ mice (Taconic Farms) were
injected subcutaneously into the right 4th mammary gland with
indicated numbers of tumor cells in 100 ml PBS using a 30-gauge
needle. Mice werepalpated for tumor formationand tumor size was
measured every 2 days by calipers. Tumor volumes calculated as
Volume (mm
3)=L 6W
260.4. Mice were sacrificed when the tumor
size exceeded 15 mm in diameter in either direction or when the
mice were moribund or at the end of the observation period (50 d).
All animal experiments were approved by the Harvard University/
FacultyofArtsand Sciences (HU/FAS)StandingCommitteeonthe
Use of Animals in Research and Teaching.
Histology and immunohistochemistry
Primary tumors and whole lung, liver and brain tissues were
dissected, fixed in 10% formalin (Sigma), embedded in paraffin,
cut into 2 mm sections and stained with hematoxylin and eosin.
For RNA isolation, mouse tissues were stored in RNAlater
(Qiagen) prior to RNA extraction using RNeasy (Qiagen). PCNA
staining in tissue sections was performed using a protocol of heat
induced antigen epitope retrieval adapted from [60]. Briefly,
paraffin was removed with xylene substitute and slides were
rehydrated with decreasing concentrations of ethanol in distilled
water. Slides were then immersed in 0.1 M citrate buffer, pH 6.0
(Lab Vision Citrate buffer for heat-induced epitope retrieval
(ThermoFisher Scientific). The slide-containing staining jars were
heated and allowed to boil for 2 min. The slides were kept in the
boiled buffer for 20 min, before cooling at RT for 30 min. Slides
were then blocked with PBS containing 5% normal donkey serum
followed by blocking in avidin-biotin solution (Vector Laborato-
ries). Endogenous peroxidase activity was quenched with 1%
H2O2. Slides were then incubated overnight at 4uC with either
polyclonal rabbit anti-PCNA antibody (Bethyl) or isotype-control
rabbit IgG. Slides were washed and then incubated for 1 hr at RT
with biotin goat anti-rabbit IgG (InnoGenex), followed by
incubation for 40 min at RT with streptavidin-HRP (InnoGenex).
The signal was developed using DAB solution according to the
manufacturer’s instructions (InnoGenex). Slides were then washed
and mounted with SUB-X mounting medium (Surgipath). For E-
cadherin staining, sections were digested with 2 mg/ml proteinase
K (Ambion) at 37uC for 30 min and cooled in RT for 10 min. The
slides were blocked with PBS containing 5% normal donkey serum
followed by treatment with the avidin-biotin blocking Kit (Vector
Laboratories). Endogenous peroxidase activity was quenched
using 1% H2O2. The slides were washed and incubated with
biotinylated goat anti-mouse Fab fragments (Sigma) for 1 hr at
RT. Slides were then incubated with streptavidin-HRP for 40 min
and the antigenic signal was amplified using the Tyramide
Amplification Kit (Invitrogen) according to the manufacturer’s
instructions. Slides were then washed and mounted with
Vectashield Mounting Medium containing DAPI (Vector Labo-
ratories). Images were acquired and analyzed using Slidebook
software (Intelligent Imaging) on a Zeiss Axiovert 200 M
microscope.
Supporting Information
Figure S1 The Zeb1 39-UTR is a target of the miR-200 family
of miRNAs. Cells were co-transfected with psiCheck2 vector that
contains the full length Zeb1 39-UTR and with miR-200b and/or
miR-200c miRNA mimics. Renilla luciferase expression was
normalized to firefly luciferase and the ratio then normalized to
that of mock-transfected cells (*, p,0.0002).
Found at: doi:10.1371/journal.pone.0007181.s001 (0.04 MB TIF)
Figure S2 PCNA staining of representative primary tumors and
metastases from BALB/c mice. Tumors and metastases derived
from implanted 4T1 cells or 4TO7 cells that were unmodified or
infected with retroviruses expressing a control miR-30 stem insert
or the miR-141-200c miRNA cluster within the miR-30 stem were
stained with PCNA.
Found at: doi:10.1371/journal.pone.0007181.s002 (0.89 MB TIF)
Table S1 miRNA expression profile of the mouse mammary
tumor cell lines based on miRNA microarray analysis. miRNAs
reporter names are referred to by their names in miRbase v9.0.
Two biological samples for each tumor cell lines were used and
two independent hybridizations (Trial 1 and Trial 2) were
performed. The dynamic range for the microarray platform is
over 5 logs. Background level is around 30 (arbitrary units) and
averaged signal shown here is background subtracted and
normalized. Detailed data analysis is described in the Materials
and Methods Section. For miRNA candidate selection, averaged
signal below 500 is considered as not detected.
Found at: doi:10.1371/journal.pone.0007181.s003 (0.12 MB
XLS)
Table S2 Primers and siRNA sequences.
Found at: doi:10.1371/journal.pone.0007181.s004 (0.03 MB
XLS)
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